Login / Signup

Analysis of Reported Adverse Events Associated with Over-the-Scope Endoscopic Suturing System: an FDA MAUDE Database Study.

Natalie WilsonMohamed AbdallahFouad JaberWillie Mohammed JohnsonNicholas McDonaldMichelle BalissShailendra SinghMohammad Bilal
Published in: Obesity surgery (2023)
The overall adverse events from the over-the-scope ESS remain acceptable as evidenced by the number of reported cases since 2008. However, it is important to note that adverse event rates might increase as the use of the device increases; therefore, it is essential for endoscopists to be aware of the potential common and rare adverse events associated with the use of the over-the-scope ESS device.
Keyphrases
  • adverse drug
  • risk assessment
  • drug induced